Limba
|
Tivantinib is the first non-ATP-competitive c-Metinhibitor with Kiof 0.355 μM in a cell-free assay, little activity to Ron, and no inhibition to EGFR, InsR, PDGFRα or FGFR1/4. Tivantinib (ARQ 197) induces a G2/M arrest and apoptosis.
Price | 1.262,00 RON (preturile sunt fara TVA) |
---|---|
Description |
Tivantinib is the first non-ATP-competitive c-Metinhibitor with Kiof 0.355 μM in a cell-free assay, little activity to Ron, and no inhibition to EGFR, InsR, PDGFRα or FGFR1/4. Tivantinib (ARQ 197) induces a G2/M arrest and apoptosis. |